Chris Fair*

Qualifications: BBA

Joined Kuros in 2021

Chris Fair has been a leader in the musculoskeletal and regenerative marketplace for over 25+ years. His expertise in commercialization and scaling operations for both biologics and device companies have made him a sought after advisor and investor. Previously Chief Operating Officer, Chris Fair became Chief Executive Officer of Kuros Biosciences in 2023.

Mr. Fair previously served as CEO & President of ControlRad, an innovative radiation reduction technology company based in Atlanta, GA and Kfar Saba, Israel. Prior to that, Mr. Fair was the Chief Executive Officer of Spinal Elements, a private equity owned operating company focused in the spinal implant marketplace. Mr. Fair has experience as Founder and CEO of Amniox Medical as well as previously operating the University of Miami Tissue Bank through its transaction to a private company. Earlier in his career, Mr. Fair served in leadership roles at MedShape Solutions, St. Francis Medical Technologies and DePuy Spine.

Mr. Fair currently sits on the Institute for Bioengineering and Bioscience Advisory Board of the Georgia Institute of Technology as well as several privately held medical and regenerative medicine technology companies.  Mr. Fair graduated from the University of Richmond Robins School of Business.

*Chris Fair is a member of the Executive Committee.